Select a category to explore research frontiers
Loading categories...
Surface modification and functionalization of nanoparticles with biological molecules for targeted delivery applications.
Current DNA nanotechnology predominantly addresses homogeneous nanoparticle assembly, leaving a critical gap in creating programmable multi-component conjugates with site-specific control over particle types and stoichiometry. This frontier addresses the challenge of rationally designing nanoarchitectures where each particle type occupies predetermined spatial coordinates.
While click chemistry enables efficient bioconjugation, there is insufficient methodology for monitoring conjugation kinetics and completion status within cellular environments without disrupting biological processes. This gap prevents real-time optimization of nanoparticle delivery and intracellular localization.
Protein-nanoparticle conjugates suffer from limited in vivo stability due to suboptimal linker design, and current empirical screening approaches cannot efficiently explore the vast peptide sequence space. AI-driven linker optimization represents an unexplored frontier for predicting thermodynamically stable configurations.
Enzymatic bioconjugation methods for nanoparticles remain limited to ex vivo applications due to incompatibility with cellular cofactors and redox environments. Developing cofactor-regenerating systems that enable in situ nanoparticle functionalization represents an underexplored frontier.
Current nanoparticle bioconjugates lack programmable temporal control over payload release and biological activity, leaving a critical gap in precision medicine applications requiring time-dependent therapeutic interventions. Stimulus-responsive linkers with multi-input logic gates remain largely unexplored.
High-density bioconjugation of nanoparticles is fundamentally limited by steric crowding that reduces biological activity of conjugated ligands, and electrostatic assembly approaches remain underutilized for controlling inter-ligand spacing. This gap prevents realization of multivalent nanoconjugates with optimal binding kinetics.
Existing protein-nanoparticle conjugation methods often require protein unfolding or site-specific mutagenesis, compromising native functionality and creating batch variability. Photochemical approaches enabling cross-linking to native conformations represent an underdeveloped frontier.
Batch chemical conjugation produces heterogeneous nanoparticle populations with uncontrolled biomolecule attachment ratios, limiting reproducibility of biomedical applications. Microfluidic approaches enabling real-time monitoring and adjustment of conjugation chemistry remain unexploited for achieving monodisperse conjugates.